[{"NetIncomeLoss_1_Q1_USD":-15885000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4274000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":23229794.0,"AccruedLiabilitiesCurrent_0_Q1_USD":5506000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":99000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":118985000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-210000.0,"Depreciation_1_Q1_USD":80000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":407250.0,"AssetsCurrent_0_Q1_USD":255982000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":2801491.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":42000.0,"CommonStockSharesIssued_0_Q1_shares":23271494.0,"Assets_0_Q1_USD":257730000.0,"ShareBasedCompensation_1_Q1_USD":2494000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":779000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":49.15,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":5.23,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-15000.0,"Liabilities_0_Q1_USD":9358000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":11495000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":20.44,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":894000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-65000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":50000.0,"PreferredStockDividendsIncomeStatementImpact_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":2000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q1_USD":3700000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1071000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":0.0,"RestrictedCash_0_Q1_USD":115000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":0.0,"IncreaseDecreaseInDeferredCharges_1_Q1_USD":0.0,"OtherAssetsCurrent_0_Q1_USD":265000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-15885000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":859000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":255203000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":361000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":42000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"OperatingIncomeLoss_1_Q1_USD":-15769000.0,"IncomeTaxesReceivable_0_Q1_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-15835000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1_Q1_shares":26734.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":24.56,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2494000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-10505000.0,"LiabilitiesCurrent_0_Q1_USD":8950000.0,"AccountsPayableCurrent_0_Q1_USD":3008000.0,"NonoperatingIncomeExpense_1_Q1_USD":-66000.0,"RestrictedCashNoncurrent_0_Q1_USD":115000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":255318000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":42000.0,"InterestExpenseDebt_1_Q1_USD":1000.0,"AdditionalPaidInCapital_0_Q1_USD":329266000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":78628.0,"PrepaidInsurance_0_Q1_USD":34000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_1_Q1_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":54632000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":854000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":779000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":0.0,"CommonStockSharesOutstanding_0_Q1_shares":23271494.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-80896000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":5059000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":70.1,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":0.53,"LiabilitiesAndStockholdersEquity_0_Q1_USD":257730000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":636000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2494000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":35700000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":436000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-10673000.0,"OperatingExpenses_1_Q1_USD":15769000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.68,"OtherLiabilitiesNoncurrent_0_Q1_USD":47000.0,"OtherLiabilitiesCurrent_0_Q1_USD":207000.0,"StockholdersEquity_0_Q1_USD":248372000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":210000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":2801491.0,"TaxesPayableCurrent_0_Q1_USD":140000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":969472.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0_Q1_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":352000.0,"Ticker":"KROS","CIK":"1664710","name":"KEROS THERAPEUTICS, INC.","OfficialName":"Keros Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1518748666.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]